Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade

Keyphrases

• Adaptive Immune Response 33%
• Adjuvant Effect 100%
• Anti-tumor Response 33%
• Antitumor Immune Response 66%
• Cancer Immunotherapy 100%
• Cancer Treatment 33%
• Cancer Types 33%
• Checkpoint Blockade 100%
• Checkpoint Blockade Agents 33%
• Clinical Outcomes 33%
• Combination Therapy 33%
• Effector Phase 33%
• Highly Heterogeneous 33%
• Immune Checkpoint Inhibitors 33%
• Innate Immunity 33%
• Mechanism of Action 33%
• Monotherapy 33%
• New Therapeutic Strategies 33%
• Novel Therapeutics 33%
• Patient Quality 33%
• Patient Response 33%
• Patient Survival 33%
• Quality of Life 33%
• Response Rate 33%
• Synthetic Agonists 33%
• Toll-like 100%
• Treatment Strategy 33%
• Tumor Cell Death 33%
• Two-agent 33%

Immunology and Microbiology

• Adaptive Immune System 33%
• Agonist 66%
• Arm 33%
• Cancer Immunotherapy 100%
• Cell Killing 33%
• Immune Response 66%
• Immunity 33%
• Immunotherapy 100%
• Innate Immune System 33%
• TLR9 100%
• Tumor Cell 33%